التفاصيل البيبلوغرافية
العنوان: |
694 Study design of a phase 3b, multicenter, randomized, double-blind, placebo-controlled trial of guselkumab (GUS) in patients with skin of color who have moderate to severe plaque and/or scalp psoriasis (VISIBLE) |
المؤلفون: |
Alexis, A., Bhutani, T., McMichael, A.J., Choi, O., Chan, D., Rowland, K., Gao, L., Park-Wyllie, L., Rodriguez, A., Kindred, C., Desai, S. |
المصدر: |
In Journal of Investigative Dermatology August 2022 142(8) Supplement:S119-S119 |
قاعدة البيانات: |
ScienceDirect |